In DNA vaccine, After plasmid construction and preparation adjuvants ,The mice were divided into 7 groups [pcDNA3/TSA, pcDNA3/TSA +dendrimer and pcDNA3/TSA.

Slides:



Advertisements
Similar presentations
Protective Immune Response in BALB/c Mice Induced by DNA Vaccine of the ROP8 gene of Toxoplasma gondii Wang chunmiao
Advertisements

JOURNAL OF PURE AND APPLIED MICROBIOLOGY, October 2011.Vol. 5(2), p Cloning, Expression and Purification of Recombinant 31kDa Cell Surface Protein.
CHOIRUNIL CHOTIMAH INTRODUCTION Leishmaniasis Leishmania Parasites promastigotes amastigotes Difficult to treat Need effective vaccine.
Making Vaccines. Effective Vaccines Have low levels of side effects or toxicity. Protect against exposure to natural, or wild forms of the pathogen. Should.
Genetic DNA Vaccines By Chelsea Heimbrock. What are DNA Vaccines? An injection of genes of a virus into the body that creates an immune response for the.
Fig. 1. Antibody response in mice immunized with VLP. Three groups of mice (n=10/group) were used in this study. Mice in groups 1 and 2 were immunized.
Evaluation of Immune Protection Elicited by Recombinant Antigen EtsC
The extract based-ointments were prepared as per the following formulation: dried plant extract (20%) was added lanolin 10% and DMSO 12% before being integrated.
OmcB PROTEIN EXPRESSED IN ADENOVIRAL VECTOR INDUCES PROTECTION AGAINST CHLAMYDIA MURIDARUM VAGINAL INFECTION Presenting author: Ekaterina A. Koroleva*,
INVOLVEMENT OF DIFFERENT SUBSETS OF REGULAOTRY T CELLS AND CYTOKINES IN THE SUPRESSION OF PRO-INFLAMMATORY RESPONCES DURING PROGRESSION OF VISCERAL LEISHMANIASIS.
Figure 1 Protective effects of acellular pertussis vaccines (A–F) in the respiratory infection model. Mice were challenged by exposure to an aerosol of.
Molecular Therapy - Oncolytics
Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania.
Volume 5, Issue 1, Pages (January 2009)
Volume 132, Issue 2, Pages (February 2007)
Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity 
Complexes of trophoblastic peptides and heat shock protein 70 as a novel contraceptive vaccine in a mouse model  Mei Han, Yuan Yao, Wangjiang Zeng, Yanfang.
Volume 8, Issue 3, Pages (September 2003)
Immunologic Characterization of HIV-Specific DNA Vaccine
Volume 15, Issue 2, Pages (February 2007)
Elisabeth Roesler, MSc, Richard Weiss, PhD, Esther E
Volume 17, Issue 8, Pages (August 2009)
Increased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice  J.
Volume 25, Issue 11, Pages (November 2017)
Molecular Therapy - Oncolytics
Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission  Yongjun Tian,
Disease Control in Cutaneous Leishmaniasis Is Independent of IL-22
CpG Methylation of a Plasmid Vector Results in Extended Transgene Product Expression by Circumventing Induction of Immune Responses  A. Reyes-Sandoval,
Parasite Clearance in Leishmaniasis in Resistant Animals Is Independent of the IL- 23/IL-17A Axis  Kirsten Dietze-Schwonberg, Beate Lorenz, Susanna Lopez.
Volume 22, Issue 7, Pages (July 2014)
Forkhead box protein 3 demethylation is associated with tolerance induction in peanut- induced intestinal allergy  Meiqin Wang, MD, PhD, Ivana V. Yang,
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1  Richard Brans,
Volume 23, Issue 3, Pages (March 2015)
Volume 4, Issue 4, Pages (October 2008)
Volume 6, Issue 4, Pages (April 1997)
Volume 15, Issue 2, Pages (February 2007)
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
Volume 25, Issue 5, Pages (May 2017)
Volume 115, Issue 4, Pages (October 1998)
Volume 26, Issue 2, Pages (February 2018)
Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: Using Dp2 peptide and fungal immunomodulatory peptide  Yi-Hsia Liu,
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
Serum IgE response to orally ingested antigen: A novel IgE response model with allergen-specific T-cell receptor transgenic mice  Kan Shida a,b, Satoshi.
Volume 23, Issue 10, Pages (October 2015)
Volume 25, Issue 4, Pages (April 2017)
IgE-class–specific immunosuppression in offspring by administration of anti-IgE to pregnant mice  Hideaki Morita, MD, PhD, Masato Tamari, MD, PhD, Masako.
The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine  Jay E. Slater, MDa, Elizabeth.
Volume 23, Issue 5, Pages (May 2018)
Volume 4, Issue 3, Pages (March 1996)
Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5% to 2% (vol/vol) oil, as measured.
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models  Fabrice Le Boeuf, Simon Gebremeskel,
Volume 13, Issue 2, Pages (February 2006)
Orally administered TGF-β is biologically active in the intestinal mucosa and enhances oral tolerance  Takashi Ando, MD, PhD, Kyosuke Hatsushika, MD,
Volume 4, Issue 4, Pages (April 1996)
Mukesh Kumar, PhDa, Aruna K. Behera, PhDa, Jianan Hu, MDa, Richard F
Volume 12, Issue 5, Pages (November 2005)
Volume 5, Issue 1, Pages (January 2009)
Immunostimulatory potential of β-lactoglobulin preparations
Volume 19, Issue 3, Pages (March 2011)
IL-10 signaling in dendritic cells attenuates anti-Leishmania major immunity without affecting protective memory responses  Mathilde J.H. Girard-Madoux,
TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies 
Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.02% to 2% (vol/vol) oil, as measured.
Volume 25, Issue 5, Pages (May 2017)
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Figure 1. T-cell immunogenicity of HZ DNA vaccines in C57BL/6 mice
Volume 28, Issue 1, Pages (January 2008)
Atsushi Yamanaka, Eiji Konishi
Fig. 6 Multivalent DNA vaccine and protein antigen delivery by T4-AAV nanoparticles. Multivalent DNA vaccine and protein antigen delivery by T4-AAV nanoparticles.
Sang Kyun Ahn, Vanessa Tran, Andrea Leung, Mark Ng, Ming Li, Jun Liu 
Fig. 2 Cxxc1 deficiency restricts T cell–mediated autoimmunity and increases sensitivity to C. rodentium infection. Cxxc1 deficiency restricts T cell–mediated.
Presentation transcript:

In DNA vaccine, After plasmid construction and preparation adjuvants ,The mice were divided into 7 groups [pcDNA3/TSA, pcDNA3/TSA +dendrimer and pcDNA3/TSA +PMMA and pcDNA3, dendrimer, PMMA and PBS].The Immunization schedule was performed with 3 inoculations (equal doses of 100 µg) with intramuscular injections at 3 week interval . The booster peptide (20 µg) and incomplete Freund’s adjuvant were subcutaneously injected two weeks after the last nano-vaccines injection. The mice were challenged intradermally with parasites (1*106 promastigotes of L.major ) , 21 days after the final immunization . The animals were then sacrificed the spleens and serum samples were harvested for immunological analysis 3 weeks after the last immunization and 3 weeks after the challenge infection. The lymphocyte proliferation was assayed with Brdu method. Cytokines( IFN-γ, IL-4) and antibodies ( Total IgG, IgG1, IgG2a) responses were assayed with ELISA method. The parasite burden was determined by draining their spleens using the limiting dilution method. Statistical comparisons between the experimental groups were carried out using analysis of variance (ANOVA) and post hoc Turkey tests. Differences were statistically considered significant when p values were less than 0.05. Results: This study showed that the new formulated vaccines were strong and effective in inducing the specific antibody and cellular responses and reducting the parasite burden in spleen compared to control groups . Please export your poster as PDF-file (File – >Save as –> PDF) and upload the PDF into the system. Please use the font in the document or a similar one and do not use a font size smaller than 18. Fig.1 Cytokine yield [IFN- γ and IL-4] by spleen cells of BALB/c mice after immunization periods and later than challenge A B Comparison of immune responses elicited by thiol-specific antioxidant-based protein vaccines and DNA vaccines with adjuvants in BALB /c mice infected with Leishmania major Fatemeh Tabatabaie1* , Narges Khabazzade Tehrani 2, Somayeh Zarrati 2 , Mehdi Mahdavi 3, Abbas ali Imani fooladi4 1- Department of Parasitology and Mycology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran 2-Microbiology Department, Science & Research Branch, Islamic Azad University, Tehran, Iran 3- Immunology Department, Pasteur Institute of Iran, Tehran, Iran 4-Applied Microbiology, Research Center, Baqiyatallah University of Medical Science, Teheran, Iran. *Corresponding author: Dr. Fatemeh Tabatabaie, Department of Parasitology and Mycology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. Tel: +98-21-86703220 Fax: +98-21-8862 2653 E-mail:Tabatabaei.f@iums.ac.ir Background and purpose: Leishmaniasis is caused by parasitic protozoa of the genus Leishmania. No effective vaccine has been developed yet against the disease. The purpose of this study was to study efficacy of DNA and protein vaccines with various adjuvants in BALB /c mice infected with Leishmania major . Material/methods: Protein vaccines were included with the recombinant TSA protein (TSA , thiol-specific antioxidant, a main antigen of Leishmania major ) and montanide ISA 70 oil adjuvant and chitosan nanoparticle . DNA vaccines were designed with TSA recombinant plasmid and dendrimer and PMMA nanoparticles (as adjuvant) . After expression and purification of the recombinant TSA protein and preparation adjuvants , BALB/c mice were divided into six groups [TSA/ high chitosan , TSA/ low chitosan , TSA/ montanide and high chitosan, low chitosan, PBS groups] and subcutaneously immunized with 20 μg of recombinant protein TSA vaccine and 40 μg of adjuvants at three times intervals on days 0, 14 and 28. Conclusions: Based on this results, we may suggest that the formulated vaccines are suitable candidates to undergo further studies in the context of leishmaniasis control. Keywords: Leishmaniasis , BALB/c mice , Adjuvants, DNA vaccines , Protein vaccines Fig.2 Cytokine production [IFN- γ(A) and IL-4(B)] by the splenocytes in vaccinated and control groups References: Badiee A, Heravi Shargh V, Khamesipour A, Jaafari MR , Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends. Vaccine ,2013 ,31:735–749 Ghaffarifar F, Tabatabaie F, Sharifi Z, Dalimiasl A, Zahir Hassan M, Mahdavi M, Cloning of a Recombinant Plasmid Encoding Thiol-Specific Antioxidant Antigen [TSA] Gene of Leishmania major and Expression in the Chinese Hamster Ovary Cell Line, Malays J Med Sci. 2012; 19[1]: 15-19 Zarrati S, Maleki F, Mahdavi M, Khabaz zadeh Tehrani N, Abrehdari Tafreshi Z , Asadi A.h. Tabatabaie F ,Humoral immune responses in DNA vaccine formulated with poly [methyl methacrylate] against Leishmania major ,India Journal of Entomology and Zoology Studies ,2014; 2 [5]: 201-206 Zarrati S, Mahdavi M, Tabatabaie F,Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major, J Parasit Dis ,2014, pp 1-9, DOI 10.1007/s12639-014-0521-8